Clinical Study Of Guizhi Decoction And Huangqi Dilong On Acute Pulmonary Thromboembolism

Objective:By using the efficacy of Guizhi Decoction and Huangqi Dilong in the treatment of low and medium risk pulmonary thromboembolism of qi deficiency and blood stasis type combined with routine anticoagulation of Western medicine,this paper explains the mechanism of clearing the surface,clearing the surface,clearing the middle and expanding the collaterals,widens the application scope of traditional clearing the surface,and puts forward a new viewpoint of "clearing the surface,clearing the middle and expanding the collaterals",so as to find a new way of thinking in the treatment of low and medium risk acute pulmonary thromboembolism in the future Effective prescription.Methods:PTE admitted to Yantai traditional Chinese medicine hospital and Yantai Yuhuangding hospital from June 2018 to December 2019 42 patients were randomly divided into two groups.All patients met the inclusion criteria.Patients in the control group were given low molecular weight heparin calcium sequential warfarin treatment.Patients in the treatment group were treated with Guizhi Decoction and Astragalus Dilong on the basis of the former.In addition,the TCM syndrome score,blood gas analysis,NT proBNP,D-2 of the two groups were compared and analyzed before and on the 14th day after treatment The differences in polymer and other aspects,and comparative analysis of the two groups of patients in the same time period after treatment,the difference in the improvement of the above items,using SPSS 22.0 statistical analysis of the target data.Results:Compared with the control group,the blood gas analysis,NT proBNP,D-dimer and other laboratory results of the patients in the treatment group decreased significantly after 14 days of treatment.In terms of the improvement of the total score of traditional Chinese medicine syndrome,the treatment group was significantly better than the control group.In terms of single traditional Chinese medicine syndrome,there was no significant difference between the control group and the treatment group in the improvement of dyspnea and chest pain symptoms,and there was no significant difference in the relief of cough and fatigue The treatment group was better than the control group.There was no significant difference in bleeding risk between the treatment group(9.5%)and the control group(4.8%)(P>0.05).Conclusion:Guizhi Decoction Combined with Huangqi Dilong combined with routine western medicine anticoagulation therapy can effectively reduce the relevant laboratory indicators,quickly improve the symptoms of patients,improve the quality of life,faster than western medicine anticoagulation therapy alone,there is no difference in reducing the risk of bleeding and other related adverse reactions.